Rajsekar R Rajaraman Selected Research

Secondary Prevention

1/2016

Prevention of infantile spasms relapse: Zonisamide and topiramate provide no benefit.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajsekar R Rajaraman Research Topics

Disease

3	Infantile Spasms (West Syndrome) 03/2020 - 01/2016
2	Spasm (Spasms) 01/2021 - 01/2020
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2018

Drug/Important Bio-Agent (IBA)

2	Zonisamide (Zonegran)FDA LinkGeneric 03/2020 - 01/2016
1	Voltage-Gated Sodium ChannelsIBA 01/2021
1	Oxcarbazepine (Trileptal)FDA LinkGeneric 01/2021
1	Lacosamide FDA Link 01/2021
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2021
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2021
1	Felbamate (Felbatol)FDA Link 01/2020
1	Prednisolone (Predate)FDA LinkGeneric 10/2019
1	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2019
1	CannabidiolIBA 01/2018
1	Topiramate (Topamax)FDA LinkGeneric 01/2016

Therapy/Procedure

1	Secondary Prevention 01/2016
1	Therapeutics 01/2016